PRAX | Praxis Precision MedicinesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$280.51
+$6.52 (+2.38%)

Praxis Precision Medicines (PRAX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $280.51 vs 50 $297.50 / 200 $314.53
Projection
No cross projected
Test
No active test
Last cross
Death cross 22 Oct 2026 ยท projected 25 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $285.93 vs 50 $304.42 / 200 $111.25
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 27 Oct 2025 ยท projected 1 bar out

4-hour as of 3 Nov 16:00 ET

Price
between the two $280.51 vs 50 $268.28 / 200 $311.76
Projection
No cross projected
Test
No active test
Last cross
Death cross 1 Oct 2026 ยท projected 28 bars out

Cross history

22
crosses on record since 2023
11 golden11 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
22 Oct 2026Death steepdaily25 bars outNot tested
1 Oct 2026Death4-hour28 bars outNot tested
23 Jul 2026Golden4-hour18 bars out5 bar cross test
10 Jun 2026Death4-hour18 bars outNot tested
week of 27 Oct 2025Golden flatweekly1 bar outNot tested

About PRAX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$129M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.